Alexis A. Thompson

12.9k citations

213 papers · 5.1k indexed · 1 hit paper · h-index 41

Genetics top 0.1%
- Hemoglobinopathies and Related Disorders 153
- Virus-based gene therapy research 14
Hematology top 0.2%
- Iron Metabolism and Disorders 63
- Blood groups and transfusion 29
Pediatrics, Perinatology and Child Health top 1%
- Prenatal Screening and Diagnostics 38
- Neonatal Health and Biochemistry 9
Family Practice top 5%
Genetics top 2%
- Hemoglobinopathies and Related Disorders 153
- Virus-based gene therapy research 14
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 12
Physiology
- Erythrocyte Function and Pathophysiology 11

Co-authors: Robert I. Liem Sherif M. Badawy Janet L. Kwiatkowski Patricia J. Giardina Ellis J. Neufeld Elliott Vichinsky John C. Wood Stella T. Chou
Cited by: Genetics Hematology Pediatrics, Perinatology and Child Health
Journals: New England Journal of Medicine (1 paper)Proceedings of the National Academy of Sciences (1 paper)The Lancet (1 paper)
Partner nations: United States United Kingdom France

In The Last Decade

Alexis A. Thompson

203 papers receiving 5.0k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Alexis A. Thompson

Since Specialization

Citations

This map shows the geographic impact of Alexis A. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexis A. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexis A. Thompson more than expected).

Fields of papers citing papers by Alexis A. Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexis A. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexis A. Thompson. The network helps show where Alexis A. Thompson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alexis A. Thompson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alexis A. Thompson Line = papers co-authored together Alexis A. Thompson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Reni-Cel, an Investigational AsCas12a Gene-Edited Cell Medicine, Led to Successful Engraftment, Increased Hemoglobin, and Reduced Transfusion Dependence in Patients with Transfusion-Dependent Beta-Thalassemia Treated in the Edithal Trial Transplantation and Cellular Therapy ·Haydar Frangoul,Rabi Hanna,Mark Walters,Kai‐Hsin Chang,Michael Jaskolka,Keunpyo Kim,Baisong Mei,Olubunmi Afonja,Alexis A. Thompson	2025	0
2	Post-Approval, Real-World Experience with Betibeglogene Autotemcel for Transfusion-Dependent Beta Thalassemia Transplantation and Cellular Therapy ·Nora M. Gibson,David F. Friedman,Caitlin W. Elgarten,Abraham Haimed,Eugene Khandros,Elizabeth Worster,Jonathan G. Bardahl,Lisa Wray,Yongping Wang,Alexis A. Thompson,Janet L. Kwiatkowski,Timothy S. Olson	2025	0
3	Betibeglogene Autotemcel (Beti-cel) Gene Addition Therapy Results in Durable Hemoglobin A (HbA) Production with up to 10 Years of Follow-up in Participants with Transfusion-Dependent β-Thalassemia Transplantation and Cellular Therapy ·Timothy S. Olson,Alexis A. Thompson,Janet L. Kwiatkowski,Jennifer Schneiderman,Isabelle Thuret,Andreas E. Kulozik,Evangelia Yannaki,Marina Cavazzana,Suradej Hongeng,Martin G. Sauer,Adrian J. Thrasher,Ashutosh Lal,John E.J. Rasko,Hancheng Jiang,Tao Ge,Himal L. Thakar,Niki Witthuhn,Mark C. Walters,Franco Locatelli	2025	0
4	Postpartum and Lactation-Related Genitourinary Symptoms Obstetrics and Gynecology ·Sara Perelmuter,Cameron Stokes,Meghana Chapalamadugu,A Drian,Gabriela Lachter Zusman,Jayden Berdugo,M Davide,Caroline Andy,Raeven Grant,Thomas Drew,Ramzy Burns,Janine Meurer,Aditi Shah,Sri Contractor,A Messafi,Alexis A. Thompson,Jill M. Krapf,Rachel Rubin	2025	1
5	The Impact of Designing Near-Peer Teacher Training According to Merrill’s First Principles of Instruction Medical Science Educator ·Kristopher Vaudrey,Marc James Thor Uy,Alexis A. Thompson,Hannah R. Morris,Lauren Cıfuentes	2024	0
6	American Society of Hematology: building a comprehensive minority recruitment and retention professional program Blood Advances ·Margo Rollins,Rahma Warsame,Melody Smith,Arturo Molina,Rayne H. Rouce,Belinda R. Avalos,Cage S. Johnson,José A. López,Alexis A. Thompson,Lisa Fanning,Patricia Frustace,Keelin F. Roche,Nathalie van Havre,Devon Mack,Christopher R. Flowers,Deirdra R. Terrell	2024	1
7	Real‐world evidence: Long‐term safety of deferiprone in a large cohort of patients with sickle cell disease enrolled in a registry for up to 10 years American Journal of Hematology ·Janet L. Kwiatkowski,Alexis A. Thompson,Fernando Tricta,Noemi Toiber Temin,Anna Rozova,Caroline Fradette,Sherif M. Badawy	2024	0
8	Safety and Efficacy Outcomes in Pediatric Patients with Transfusion-Dependent β-Thalassemia (TDT) Receiving Betibeglogene Autotemcel (beti-cel; LentiGlobin for β-thalassemia) Gene Therapy in the Phase 3 Hgb-207 (Northstar-2) and Hgb-212 (Northstar-3) Studies Transplantation and Cellular Therapy ·Mark C. Walters,Janet L. Kwiatkowski,John B. Porter,Suradej Hongeng,Evangelia Yannaki,Andreas E. Kulozik,Martin G. Sauer,Adrian J. Thrasher,Isabelle Thuret,Ashutosh Lal,Ruiting Guo,Weijian Liu,Richard A. Colvin,Franco Locatelli,Alexis A. Thompson	2021	1
9	Resolution of Serious Vaso-Occlusive Pain Crises: Results from the Ongoing Phase 1/2 HGB-206 Group C Study of LentiGlobin for Sickle Cell Disease (SCD; bb1111) Gene Therapy Transplantation and Cellular Therapy ·Mark C. Walters,Alexis A. Thompson,Markus Y. Mapara,Janet L. Kwiatkowski,Lakshmanan Krishnamurti,Banu Aygün,Kimberly A. Kasow,Stacey Rifkin-Zenenberg,Manfred Schmidt,Jay DelCarpini,Francis J. Pierciey,Alex Miller,Ren Chen,Sunita Goyal,Julie Kanter,John F. Tisdale	2021	1
10	Efficacy and Safety of Betibeglogene Autotemcel (beti-cel; LentiGlobin for β-thalassemia) Gene Therapy in 60 Patients with Transfusion-Dependent β-Thalassemia (TDT) Followed for up to 6 Years Post-Infusion Transplantation and Cellular Therapy ·Suradej Hongeng,Alexis A. Thompson,Janet L. Kwiatkowski,Franco Locatelli,John B. Porter,John E.J. Rasko,Marina Cavazzana,Martin G. Sauer,Adrian J. Thrasher,Isabelle Thuret,Ashutosh Lal,Andreas E. Kulozik,Evangelia Yannaki,Manfred Schmidt,Ying Chen,Ruiting Guo,Weijian Liu,Richard A. Colvin,Mark C. Walters	2021	1
11	A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy Blood Advances ·Sherif M. Badawy,Usman Beg,Robert I. Liem,Sonali Chaudhury,Alexis A. Thompson	2021	42
12	Favorable Outcomes in Pediatric Patients in the Phase 3 Hgb-207 (Northstar-2) and Hgb-212 (Northstar-3) Studies of Betibeglogene Autotemcel Gene Therapy for the Treatment of Transfusion-Dependent β-Thalassemia Blood ·Alexis A. Thompson,Janet L. Kwiatkowski,John B. Porter,Suradej Hongeng,Evangelia Yannaki,Andreas E. Kulozik,Martin G. Sauer,Adrian J. Thrasher,Isabelle Thuret,Ashutosh Lal,Ruiting Guo,Weijian Liu,Richard A. Colvin,Mark C. Walters,Franco Locatelli	2020	7
13	Long-Term Efficacy and Safety of Betibeglogene Autotemcel Gene Therapy for the Treatment of Transfusion-Dependent β-Thalassemia: Results in Patients with up to 6 Years of Follow-up Blood ·Janet L. Kwiatkowski,Mark C. Walters,Suradej Hongeng,Franco Locatelli,John E.J. Rasko,Marina Cavazzana,Ying Chen,Richard A. Colvin,Alexis A. Thompson	2020	8
14	Association between Participants’ Characteristics, Patient-Reported Outcomes, and Clinical Outcomes in Youth with Sickle Cell Disease BioMed Research International ·Sherif M. Badawy,Leonardo Barrera,Stephanie W. Cai,Alexis A. Thompson	2018	32
15	Healthcare utilization and hydroxyurea adherence in youth with sickle cell disease Pediatric Hematology and Oncology ·Sherif M. Badawy,Alexis A. Thompson,Jane L. Holl,Frank J. Penedo,Robert I. Liem	2018	43
16	Patient-Centered eHealth Interventions for Children, Adolescents, and Adults With Sickle Cell Disease: Systematic Review Journal of Medical Internet Research ·Sherif M. Badawy,Robert M. Cronin,Jane S. Hankins,Lori E. Crosby,Michael R. DeBaun,Alexis A. Thompson,Nirmish Shah	2018	113
17	Adherence to hydroxyurea, health-related quality of life domains, and patients’ perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults Health and Quality of Life Outcomes ·Sherif M. Badawy,Alexis A. Thompson,Jin‐Shei Lai,Frank J. Penedo,Karen Rychlik,Robert I. Liem	2017	68
18	Barriers to hydroxyurea adherence and health‐related quality of life in adolescents and young adults with sickle cell disease European Journal Of Haematology ·Sherif M. Badawy,Alexis A. Thompson,Frank J. Penedo,Jin‐Shei Lai,Karen Rychlik,Robert I. Liem	2017	64
19	Medication Adherence and Technology-Based Interventions for Adolescents With Chronic Health Conditions: A Few Key Considerations JMIR mhealth and uhealth ·Sherif M. Badawy,Alexis A. Thompson,Lisa M. Kuhns	2017	66
20	Widespread B29 (CD79b) Gene Defects and Loss of Expression in Chronic Lymphocytic Leukemia Leukemia & lymphoma ·Alexis A. Thompson,Ha Nancy,Andrew Saxon,Randolph Wall	1999	16

About Alexis A. Thompson

Alexis A. Thompson is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health, having authored 213 papers that have together received 5.1k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (153 papers), Iron Metabolism and Disorders (63 papers), Prenatal Screening and Diagnostics (38 papers), Blood groups and transfusion (29 papers), Virus-based gene therapy research (14 papers), Acute Lymphoblastic Leukemia research (12 papers), Erythrocyte Function and Pathophysiology (11 papers) and Neonatal Health and Biochemistry (9 papers). The work is most often cited by research in Genetics (3.1k citations), Hematology (2.7k citations) and Pediatrics, Perinatology and Child Health (980 citations). Alexis A. Thompson has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Robert I. Liem, Sherif M. Badawy, Janet L. Kwiatkowski, Patricia J. Giardina, Ellis J. Neufeld, Elliott Vichinsky, John C. Wood, Stella T. Chou, Thomas D. Coates and Frank J. Penedo. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact